CTRI/2024/11/076199尚未招募不适用
Prevalence of Ocular surface Disease in patients with Glaucoma on topical Anti Glaucoma medications
Dr H Harshitha Yelamanchi1 个研究点 分布在 1 个国家目标入组 157 人开始时间: 2024年11月5日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 157
- 试验地点
- 1
- 主要终点
- Assess Lipiview,Schirmers test,TBUT, and ocular surface grading
研究概览
简要总结
THIS STUDY IS OBSERVATIONAL CROSS SECTIONAL STUDY AIMED TO INVESTIGATE THE EFFECT OF TOPICAL GLAUCOMA MEDICATIONS ON LIPID LAYER THICKNESS AND MEIBOMIAN GLAND DYSFUNCTION USING LIPIVIEW INTERFEROMETER,TEAR FILM BREAK UP TIME,SCHIRMER TEST,CORNEAL AND CONJUNCTIVAL SCORES
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients diagnosed with Glaucoma and using topical medications for atleast 6 months.
排除标准
- •Patients on other topical drugs with preservatives Current use of contact lenses.
- •Presence of Pterygium Previous ocular surgeries Recent clear corneal cataract surgery in last 3 months.
结局指标
主要结局
Assess Lipiview,Schirmers test,TBUT, and ocular surface grading
时间窗: 6 months
次要结局
未报告次要终点
研究者
Dr. H Harshitha Yelamanchi
Sankara Eye Hospital
研究点 (1)
Loading locations...
相似试验
已完成
4 期
A high prevalence of ocular surface disease among glaucoma patients in thailandPrimary open angle glaucomaocular surface disease,glaucoma,thailandTCTR20170508001no58
已完成
不适用
Epidemiological study related to ocular surface factors for all residents in Takushima island, Hirado, NagasakiOcular surface diseasesJPRN-UMIN000028310id and Meibomian gland working group652
已完成
不适用
Prevalence of Ocular Surface Disease in Glaucoma PatientsGlaucomaNCT00382122Alcon Research101
招募中
不适用
Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant TreatmentBlepharitisNCT07431385Fidia Farmaceutici s.p.a.80
Enrolling By Invitation
不适用
Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients With Graves DiseaseNCT07332988Grigore T. Popa University of Medicine and Pharmacy30